Thats why we combed Reddit to find out what people are currently talking about in obesity and GLP-1 communities and asked the following medical experts to respond to readers most pressing questions: Kia Mitchell, MD Double board-certified family and obesity medicine physician and founder of the International Womens Obesity Network Marsha Novick, MD, FAAFP Spokesperson for The Obesity Society and board member of the American Board of Obesity Medicine Richele Corrado, DO, MPH Spokesperson for The Obesity Society and medical director, internist, and obesity medicine physician at Revolution Medicine, Health & Fitness Sherrie Singh-Bryan, PharmD, CDCES Clinical pharmacist and certified diabetic care and education specialist at Winn Army Community Hospital in Fort Stewart, Georgia Editors note: These interviews have been edited for length and clarity
Understanding the medication Before starting the medication, understand your prescribed dosage, administration instructions, and potential side effects
In people with type 2 diabetes, the incretin effect is often diminished, contributing to poor glycaemic control
The focus is on adopting a reduced-calorie diet and healthier eating patterns whilst managing potential gastrointestinal side effects during treatment
We continue to believe that identifying a single methodology across all Advanced APMs may offer certain benefits related to consistency and transparency across the Advanced APM program, and we remain committed to ensuring that our policies support participation in Advanced APMs
doi:10.1111/bcp.12777 Simental-Menda LE, Snchez-Garca A, Linden-Torres E, Simental-Menda M
